Recombinant Protein Therapeutics
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
607
NCT06277167
A Phase I Study in Healthy Participants
Phase: Phase 1
Role: Lead Sponsor
Start: Jan 7, 2023
Completion: Apr 21, 2023
NCT06363370
Human Interferon α1b Inhalation Solution Against Respiratory Syncytial Virus in Children With Lower Respiratory Tract Infections
Phase: Phase 3
Start: Mar 27, 2024
Completion: Jun 30, 2026
NCT06711523
Study Evaluating PEG-G-CSF Injectionin Preventing Neutropenia After Chemotherapy
Start: Dec 31, 2024
Loading map...